newsfilter
← Latest News
Business Wire·

Alzamend Neuro Issues Letter to Stockholders

Alzamend recently announced partnership with Massachusetts General Hospital for five phase II clinical trials of AL001, involving healthy human subjects and patients with Alzheimer's, BD, MDD and PTSD Alzamend has